In this minireview, we aim to shed light on the roles of PBRM1, SETD2, and BAP1 in the tumor metabolic and immune microenvironments, and discuss how these functions could benefit the management of advanced ccRCC. The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.